General Session
(GS-1) Prostate Cancer Diagnosis and Treatment of Localized Disease

Thursday January 10, 2019 | 07:45 to 09:30
Room: Pier 4&5


MRI : Where do we stand in 2019?
Dr. Masoom Haider, Canada
Mount Sinai Hospital, Toronto

Biomarkers: From diagnosis to risk stratification
Dr. Frédéric Pouliot, Canada
Université Laval, Quebec

Active surveillance: Long term data. We continue to learn.
Lawrence Klotz, Canada
University of Toronto, Toronto

Current radiotherapeutic approaches to treating localized disease
Tamim Niazi, Canada
McGill, Montreal

Treating M0 or nmCRPC
Neil Fleshner, Canada
University of Toronto,

All Participants, Canada

© 2019 CUOS 2019